The Food and Drug Administration has revealed potential vulnerabilities in St. Jude Medical's implantable cardiac devices. The agency on Monday confirmed flaws in the Merlin@home
Transmitter, leaving embedded pacemakers and defibrillators open to attack. According to the FDA, an unauthorized user could remotely access a patient's radio frequency-enabled implant, then modify
programming commands to quickly deplete the battery or administer inappropriate pacing or shocks.
Read the whole story at PC Magazine »